Quality of life for caregivers of myeloma patients
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This study looks at how caring for someone with multiple myeloma affects your daily life and well-being. It aims to understand your experiences and needs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You are the main person helping a patient with multiple myeloma during their first treatment
- You help them at least once a week with things like shopping, cleaning, or personal care
- You speak and understand French
- You have French social security coverage (not state medical aid)
- You agree to take part and can give written consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the well-being of family or friends who care for an older person (70+) with cancer. It aims to understand how caregiving affects their quality of life.
This study looks at how multiple myeloma and its treatment affect the daily life, well-being, and social activities of patients and their caregivers. It aims to understand what factors influence their quality of life.
This study offers a palliative care team (doctors and nurses focused on comfort and quality of life) to people newly diagnosed with multiple myeloma or with an aggressive lymphoma that has come back. The goal is to help manage symptoms early, so you feel better and stay stronger during your cancer treatment.
This study follows people with symptomatic multiple myeloma who live in the West-Occitanie region. It aims to better understand patients’ experiences and needs over time, which may help improve care and support.
This study looks at how multiple myeloma (a bone marrow cancer) changes over time, especially why it becomes resistant to treatment or comes back. It may help researchers learn what drives relapse and could lead to better future treatments.
This study tests an approach to help people with certain blood cancers and their main caregiver plan ahead and communicate more clearly about end-of-life care. It may help patients feel more supported and better prepared for difficult decisions.
Hear when a new Caregivers of Patients With Multiple Myeloma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.